PTAB Invalidates Purple Leaf Patents Following IPR Challenges from Askeladden
The Patent Trial and Appeals Board found the claims of the two payments-related patents to be unpatentable.
PTAB Grants Askeladden's Request for IPR of Verify Smart Patent
Askeladden asserted that the patent's claims related to identity verification in electronic transactions are invalid as obvious.
Askeladden Files Amicus Brief in Oil States v. Greene’s Energy Group
Argues that IPR and CBM processes play a critical role in improving patent quality.
Our Mission
To improve patent quality, supporting good IP practices, and addressing questionable patent holder behaviors.
Why Patent Quality Matters
Low-quality patents stifle innovation and exposes companies to frivolous, expensive lawsuits.
Learn more about our efforts to improve the understanding, use and reliability of patents in financial services and elsewhere.
Answers to the most common questions about the Patent Quality Initiative.
Your resource on patent litigation and IPR filings.
Askeladden Advocates against Tribal Sovereign Immunity for Inter Partes Review Proceedings
May 21, 2018
Submitted amicus brief in support of PTAB’s decision finding tribal sovereign immunity inapplicable in six IPRs involving Restasis® patents
PTAB Finds N5 Technologies Patent to be Unpatentable Following Challenge from Askeladden
April 25, 2018
Askeladden successfully proves that all eleven claims of the mobile authentication patent were unpatentable.
Askeladden Petitions for Review of Digital Verification Systems Patent
March 7, 2018
Argues that prior art renders all claims anticipated or obvious.
PTAB Denies St. Regis Mohawk Tribe’s Request for Sovereign Immunity in Challenges of Restasis Patents
Askeladden filed an amicus brief arguing against applicability of tribal sovereign immunity in IPR proceedings.
February 15, 2018
The Patent Trial and Appeal Board found the claims of the two payments-related patents to be unpatentable.
Askeladden Advocates against Tribal Sovereign Immunity in Patent Review Proceedings
December 4, 2017
Askeladden argues that the Tribe’s motion to dismiss should be denied because Tribal Sovereign Immunity does not apply to administrative proceedings like IPRs before the Patent Trial and Appeal Board.
